714
Views
22
CrossRef citations to date
0
Altmetric
Reviews

New treatment strategies and emerging drugs in endometriosis

, MD, , MD, , MD PhD, , MD, , MD PhD & , MD
Pages 83-104 | Published online: 23 Mar 2012
 

Abstract

Introduction: Endometriosis, histologically defined as the presence of endometrium-like tissue – glands and stroma – that develops outside of the uterine cavity, is still an enigmatic disease responsible for pelvic pain and infertility. The current treatments of endometriosis are surgery and hormonal therapies that act by suppressing ovulation and/or directly on steroid receptors located in endometriotic lesions.

Areas covered: New hormonal and non-hormonal therapies are being developed for the treatment of endometriosis-related pain. The authors review the state of advancement and the results of novel treatments studied in registered trials (www.ClinicalTrials.gov). Cellular signaling pathways activated in endometriotic cells, which constitute potential targets for future treatments, are also described.

Expert opinion: Therapeutic research efforts should focus on identifying and testing substances capable of acting locally on the lesions themselves, without interfering with ovulation, in order to be efficacious on both pain symptoms and infertility.

Acknowledgments

The authors thank MC Streuli for reviewing the English language of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.